GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study

Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med. 1976;295:417–20.

PubMed  CAS  Google Scholar 

Yazdanpanah S, Rabiee M, Tahriri M, Abdolrahim M, Rajab A, Jazayeri HE, et al. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: a comprehensive review. Crit Rev Clin Lab Sci. 2017;54:219–32.

PubMed  CAS  Google Scholar 

MacRury SM, Kilpatrick ES, Paterson KR, Dominiczak MH. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients. Clin Chim Acta. 1991;199:51–8.

PubMed  CAS  Google Scholar 

Jung C-H, Lee B, Choi D-H, Jung S-H, Kim B-Y, Kim C-H, et al. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2017;125:53–61.

PubMed  CAS  Google Scholar 

Koga M, Inada S, Nakao T, Kawamori R, Kasayama S. The Glycated Albumin (GA) to HbA1c ratio reflects shorter-term glycemic control than GA: analysis of patients with fulminant type 1 diabetes. J Clin Lab Anal. 2017. https://doi.org/10.1002/jcla.22023.

Article  PubMed  Google Scholar 

Kinoshita T, Shimoda M, Sanada J, Fushimi Y, Hirata Y, Irie S, et al. Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus. J Diabetes Complicat. 2016;30:1452–5.

Google Scholar 

Lee S-H, Jang MU, Kim Y, Park SY, Kim C, Kim YJ, et al. Effect of prestroke glycemic variability estimated glycated albumin on stroke severity and infarct volume in diabetic patients presenting with acute ischemic stroke. Front Endocrinol. 2020;11:230.

Google Scholar 

Moon JH, Chae MK, Kim KJ, Kim HM, Cha BS, Lee HC, et al. Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease. Circ J. 2012;76:2273–9.

PubMed  CAS  Google Scholar 

Xu Y, Ma X, Shen Y, Wang Y, Zhou J, Bao Y. Increasing waist circumference is associated with decreased levels of glycated albumin. Clin Chim Acta. 2019;495:118–22.

PubMed  CAS  Google Scholar 

Jeon WS, Park SE, Rhee E-J, Lee W-Y, Oh K-W, Park S-W, et al. The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2016;116:46–53.

PubMed  CAS  Google Scholar 

Raghav A, Ahmad J, Noor S, Alam K, Mishra BK. Glycated albumin and the risk of chronic kidney disease in subjects with type 2 diabetes: a study in North Indian population. Diabetes Metab Syndr. 2018;12:381–5.

PubMed  Google Scholar 

Ikeda Y, Hisakawa N, Takata H, Ohguro T, Nishiuchi J, Kumon Y. The ratio of glycated albumin to glycated hemoglobin is associated with insulin resistance-related features in non-diabetic Japanese subjects. Atherosclerosis. 2018;275: e199.

Google Scholar 

Maruo S, Motoyama K, Hirota T, Kakutani Y, Yamazaki Y, Morioka T, et al. Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes. Diabetol Int. 2020;11:368–75.

PubMed  PubMed Central  Google Scholar 

Fukui M, Tanaka M, Hasegawa G, Yoshikawa T, Nakamura N. Association between serum bioavailable testosterone concentration and the ratio of glycated albumin to glycated hemoglobin in men with type 2 diabetes. Diabetes Care. 2008;31:397–401.

PubMed  CAS  Google Scholar 

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202–9.

PubMed  Google Scholar 

Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10:284–96.

PubMed  Google Scholar 

Guo B, Guo Y, Nima Q, Feng Y, Wang Z, Lu R, et al. Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. J Hepatol. 2022;76:518–25.

PubMed  CAS  Google Scholar 

Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, et al. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis. World J Hepatol. 2012;4:11–7.

PubMed  PubMed Central  Google Scholar 

Enomoto H, Aizawa N, Nakamura H, Sakai Y, Iwata Y, Tanaka H, et al. An increased ratio of glycated albumin to HbA1c Is associated with the degree of liver fibrosis in hepatitis B virus-positive patients. Gastroenterol Res Pract. 2014;2014: 351396.

PubMed  PubMed Central  Google Scholar 

Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M. Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem. 2009;46:368–72.

PubMed  CAS  Google Scholar 

Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta. 2007;378:48–52.

PubMed  CAS  Google Scholar 

Ke J-F, Wang J-W, Lu J-X, Zhang Z-H, Liu Y, Li L-X. Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes. Diabetes Res Clin Pract. 2022;183: 109151.

PubMed  CAS  Google Scholar 

Ke J-F, Wang J-W, Zhang Z-H, Chen M-Y, Lu J-X, Li L-X. Insulin therapy is associated with an increased risk of carotid plaque in type 2 diabetes: a real-world study. Front Cardiovasc Med. 2021;8: 599545.

PubMed  PubMed Central  CAS  Google Scholar 

Liu F, Chen S, Zhao W, Chen M, Ke J, Zhang Z, et al. Urine uric acid excretion levels are positively associated with obesity and abdominal obesity in type 2 diabetes patients without chronic kidney disease. Diabetes Metab Syndr Obes. 2021;14:4691–703.

PubMed  PubMed Central  CAS  Google Scholar 

Zhang Z-H, Ke J-F, Lu J-X, Liu Y, Wang A-P, Li L-X. Serum retinol-binding protein levels are associated with nonalcoholic fatty liver disease in chinese patients with type 2 diabetes mellitus: a real-world study. Diabetes Metab J. 2022;46:129–39.

PubMed  Google Scholar 

Zhao C-C, Wang A-P, Li L-X, Li T-T, Chen M-Y, Zhu Y, et al. Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. J Diabetes Complications. 2016;30:1074–80.

PubMed  Google Scholar 

Tanaka C, Saisho Y, Tanaka K, Kou K, Tanaka M, Meguro S, et al. Factors associated with glycemic variability in Japanese patients with diabetes. Diabetol Int. 2014;5:36–42.

Google Scholar 

Song SO, Kim KJ, Lee B-W, Kang ES, Cha BS, Lee HC. Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis. 2012;225:450–5.

PubMed  CAS  Google Scholar 

Hong N, Lee M, Park S, Lee Y, Jin S-M, Kim JH, et al. Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease. Sci Rep. 2018;8:6710.

PubMed  PubMed Central  Google Scholar 

Baynes JW, Thorpe SR, Murtiashaw MH. Nonenzymatic glucosylation of lysine residues in albumin. Methods Enzymol. 1984;106:88–98.

PubMed  CAS  Google Scholar 

Ciardullo S, Rea F, Perseghin G. Glycated albumin is associated with all-cause and cardiovascular mortality among U.S. adults with and without diabetes: a retrospective cohort study. Nutr Metab Cardiovasc Dis. 2022. https://doi.org/10.1016/j.numecd.2022.07.008.

Article  PubMed  Google Scholar 

Bando Y, Kanehara H, Aoki K, Toya D, Notsumata K, Tanaka N, et al. The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis. Ann Clin Biochem. 2012;49:387–90.

PubMed  CAS  Google Scholar 

Li T-T, Wang A-P, Lu J-X, Chen M-Y, Zhao C-C, Tang Z-H, et al. Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes. Diabetes Metab. 2018;44:437–43.

PubMed  Google Scholar 

Mukai N, Ohara T, Hata J, Hirakawa Y, Yoshida D, Kishimoto H, et al. Alternative measures of Hyperglycemia and risk of alzheimer’s disease in the community: the Hisayama study. J Clin Endocrinol Metab. 2017;102:3002–10.

PubMed  Google Scholar 

Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147–52.

PubMed  PubMed Central  CAS  Google Scholar 

Huh JH, Kim KJ, Lee B-W, Kim DW, Kang ES, Cha BS, et al. The relationship between BMI and glycated albumin to glycated hemoglobin (GA/A1c) ratio according to glucose tolerance status. PLoS ONE. 2014;9: e89478.

PubMed  PubMed Central  Google Scholar 

Kurebayashi S. Sitagliptin significantly decreases the ratio of glycated albumin to HbA1c in patients with type 2 diabetes mellitus. J Diabetes Metab. 2014. https://doi.org/10.4172/2155-6156.1000343.

Article  Google Scholar 

Koga M, Matsumoto S, Saito H, Kasayama S. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J. 2006;53:387–91.

PubMed  CAS  Google Scholar 

Miyashita Y, Nishimura R, Morimoto A, Matsudaira T, Sano H, Tajima N. Glycated albumin is low in obese, type 2 diabetic patients. Diabetes Res Clin Pract. 2007;78:51–5.

PubMed  CAS  Google Scholar 

He X, Mo Y, Ma X, Ying L, Zhu W, Wang Y, et al. Associations of body mass index with glycated albumin and glycated albumin/glycated hemoglobin A1c ratio in Chinese diabetic and non-diabetic populations. Clin Chim Acta. 2018;484:117–21.

PubMed  CAS  Google Scholar 

Ciardullo S, Grassi G, Mancia G, Perseghin G. Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34:365–71.

PubMed  CAS  Google Scholar 

Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54:1082–90.

PubMed  Google Scholar 

Alam MS, Kamrul-Hasan A, Kalam ST, Rahman SM, Hoque MI, Islam MdB, et al. Liver stiffness measurement by using transient elastography in Bangladeshi patients with type 2 diabetes mellitus and ultrasonography-diagnosed nonalcoholic fatty liver disease. DMSO. 2021;14:3089–96.

Google Scholar 

留言 (0)

沒有登入
gif